Eugia Pharma Specialities Ltd receives 7 observations from USFDA for Unit II

The United States Food and Drug Administration (US FDA) inspected Unit-II, a Formulation manufacturing facility, of Eugia Pharma Specialities Ltd., a wholly owned subsidiary of AUROBINDO PHARMA LIMITED, situated at Bhiwadi, Alwar, Rajasthan, from April 25th to May 3rd 2024.

The inspection closed with 7 observations. The observations are procedural in nature and will be responded to within the stipulated time.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1152.70 as compared to the previous close of Rs. 1153.85. The total number of shares traded during the day was 22801 in over 1189 trades.

The stock hit an intraday high of Rs. 1169.35 and intraday low of 1146.25. The net turnover during the day was Rs. 26414038.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 EugiaPharmaSpecialities USFDA 7Observations Unit2